Deciphering 17β-estradiol-3-sulfate biotransformation: From microbial interactions to strain-level biotransformation
Wei Zhang1, Qingmiao Yu1, Hongpu Xue1
1Key Laboratory of the Three Gorges Reservoir Region's Eco-Environment, Ministry of Education, Chongqing University, Chongqing 400044, China.
Biodegradation effectively removes 17β-estradiol-3-sulfate (E2-3S) from wastewater. Pseudomonas species are key to reducing estrogenic activity, with isolated strain CE2S showing high degradation efficiency.
Area of Science:
- Environmental Microbiology
- Biotechnology
- Wastewater Treatment
Background:
- 17β-estradiol-3-sulfate (E2-3S) is an environmental estrogen of concern in wastewater.
- Biodegradation offers a promising but mechanistically unclear method for E2-3S removal.
Purpose of the Study:
- To elucidate the mechanisms of E2-3S biodegradation at both microbial community and individual strain levels.
- To identify key microbial players and pathways involved in E2-3S degradation and estrogenic activity reduction.
Main Methods:
- Construction of microbial co-occurrence networks in various reaction environments.
- Isolation and characterization of E2-3S-degrading bacteria from activated sludge.
- Analysis of degradation pathways and estrogenic activity reduction by isolated strains.
Main Results:
- Activated sludge achieved over 90% E2-3S removal, with variable estrogenic activity reduction.
- Pseudomonas species were identified as keystone taxa, interacting synergistically with other bacteria.
- Isolated strain Pseudomonas CE2S demonstrated high E2-3S degradation (>90%) and estrogenic activity reduction (>70%).
- Proposed E2-3S degradation pathways for strain CE2S involve deconjugation, hydroxylation, and ring cleavage.
Conclusions:
- This study provides a comprehensive mechanistic understanding of E2-3S biodegradation from community to strain levels.
- The isolation of Pseudomonas CE2S offers a novel bioaugmentation candidate for simultaneous E2-3S degradation and estrogenic activity reduction in wastewater treatment.
More Related Videos
09:49Prospecting Microbial Strains for Bioremediation and Probiotics Development for Metaorganism Research and Preservation
Published on: October 31, 2019
08:03A Tandem Liquid Chromatography–Mass Spectrometry-based Approach for Metabolite Analysis of Staphylococcus aureus
Published on: March 28, 2017
Related Concept Videos
Drug Biotransformation: Overview
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Drug Metabolism: Phase II Reactions
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
